BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Kurume
State: Fukuoka
Zip:
Country: Japan
BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies. The company develops products based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens.
Contact Phone:
Contact Email:
Listed Exchange:
TYO
IPO Date:
10/22/2015
Ticker Symbol:
4594
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2010 | Seed Round | 1 | - |
DBJ Capital DBJ Capital |
1/2009 | Funding Round | 1 | - |
Fast Track Initiative, Inc. Fast Track Initiative, Inc. |
8/2014 | Venture Round | 6 | $11.5M |
Ibis Capital Partners Innovation Engine KSP MBLVC Nippon Venture Capital Sansei Capital Investment Ibis Capital Partners Innovation Engine KSP MBLVC Nippon Venture Capital Sansei Capital Investment |
12/2010 | Seed Round | 1 | - |
DBJ Capital DBJ Capital |
1/2009 | Funding Round | 1 | - |
Fast Track Initiative, Inc. Fast Track Initiative, Inc. |
---|
Announced Date | Name | Price |
---|---|---|
11/2016 | Advanced Immunotherapy |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|